Compare EH & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EH | STAA |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 867.9M |
| IPO Year | 2019 | 1995 |
| Metric | EH | STAA |
|---|---|---|
| Price | $12.40 | $19.77 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 10 |
| Target Price | $21.85 | ★ $23.36 |
| AVG Volume (30 Days) | 471.9K | ★ 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $313,901,000.00 |
| Revenue This Year | $10.53 | N/A |
| Revenue Next Year | $81.37 | $22.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.23 | $14.69 |
| 52 Week High | $25.79 | $30.81 |
| Indicator | EH | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 48.00 | 56.37 |
| Support Level | $11.23 | $16.02 |
| Resistance Level | $14.59 | $19.94 |
| Average True Range (ATR) | 0.43 | 0.84 |
| MACD | 0.14 | 0.54 |
| Stochastic Oscillator | 76.06 | 84.10 |
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.